Vanguard Group’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$216M Sell
7,572,075
-64,118
-0.8% -$1.74M ﹤0.01% 1511
2025
Q3
$225M Sell
7,636,193
-160,269
-2% -$4.38M ﹤0.01% 1488
2025
Q2
$225M Buy
7,796,462
+1,044,851
+15% +$30.9M ﹤0.01% 1458
2025
Q1
$236M Sell
6,751,611
-65,801
-1% -$2.68M ﹤0.01% 1407
2024
Q4
$304M Buy
6,817,412
+764,900
+13% +$31.3M 0.01% 1331
2024
Q3
$276M Buy
6,052,512
+1,164,289
+24% +$47.1M ﹤0.01% 1367
2024
Q2
$162M Buy
4,888,223
+9,080
+0.2% +$371K ﹤0.01% 1605
2024
Q1
$234M Buy
4,879,143
+37,733
+0.8% +$2.2M ﹤0.01% 1411
2023
Q4
$357M Buy
4,841,410
+44,770
+0.9% +$3.03M 0.01% 1180
2023
Q3
$350M Sell
4,796,640
-95,197
-2% -$7.6M 0.01% 1108
2023
Q2
$405M Buy
4,891,837
+1,245
+0% +$109K 0.01% 1050
2023
Q1
$436M Buy
4,890,592
+91,981
+2% +$8M 0.01% 986
2022
Q4
$411M Buy
4,798,611
+333,173
+7% +$28.2M 0.01% 990
2022
Q3
$319M Sell
4,465,438
-36,464
-0.8% -$3.26M 0.01% 1098
2022
Q2
$437M Buy
4,501,902
+1,067,252
+31% +$109M 0.01% 943
2022
Q1
$386M Buy
3,434,650
+8,570
+0.3% +$913K 0.01% 1127
2021
Q4
$462M Sell
3,426,080
-54,243
-2% -$7.55M 0.01% 1048
2021
Q3
$491M Sell
3,480,323
-382,848
-10% -$51.5M 0.01% 981
2021
Q2
$495M Buy
3,863,171
+79,080
+2% +$9.31M 0.01% 996
2021
Q1
$484M Buy
3,784,091
+179,542
+5% +$33.1M 0.01% 970
2020
Q4
$648M Buy
3,604,549
+91,013
+3% +$20.2M 0.02% 753
2020
Q3
$771M Sell
3,513,536
-66,351
-2% -$14.8M 0.03% 603
2020
Q2
$801M Sell
3,579,887
-219,951
-6% -$34.5M 0.03% 573
2020
Q1
$372M Buy
3,799,838
+120,071
+3% +$9.71M 0.02% 800
2019
Q4
$276M Buy
3,679,767
+80,486
+2% +$5.2M 0.01% 1190
2019
Q3
$221M Buy
3,599,281
+147,435
+4% +$8.87M 0.01% 1275
2019
Q2
$205M Buy
3,451,846
+250,095
+8% +$15M 0.01% 1342
2019
Q1
$210M Buy
3,201,751
+162,461
+5% +$9.83M 0.01% 1311
2018
Q4
$148M Buy
3,039,290
+109,903
+4% +$6.56M 0.01% 1438
2018
Q3
$191M Buy
2,929,387
+152,702
+5% +$10.7M 0.01% 1421
2018
Q2
$185M Buy
2,776,685
+335,321
+14% +$20.3M 0.01% 1400
2018
Q1
$126M Buy
2,441,364
+17,104
+0.7% +$796K 0.01% 1581
2017
Q4
$105M Buy
2,424,260
+93,129
+4% +$3.81M ﹤0.01% 1683
2017
Q3
$102M Buy
2,331,131
+136,030
+6% +$4.73M ﹤0.01% 1704
2017
Q2
$59.6M Buy
2,195,101
+68,549
+3% +$1.7M ﹤0.01% 1934
2017
Q1
$48.1M Buy
2,126,552
+87,995
+4% +$1.82M ﹤0.01% 2031
2016
Q4
$43.7M Buy
2,038,557
+42,287
+2% +$907K ﹤0.01% 2042
2016
Q3
$44.1M Buy
1,996,270
+32,749
+2% +$699K ﹤0.01% 1987
2016
Q2
$35.1M Buy
1,963,521
+32,681
+2% +$565K ﹤0.01% 2057
2016
Q1
$33.3M Sell
1,930,840
-55,279
-3% -$925K ﹤0.01% 2060
2015
Q4
$42.1M Buy
1,986,119
+24,740
+1% +$502K ﹤0.01% 1961
2015
Q3
$37M Buy
1,961,379
+9,756
+0.5% +$209K ﹤0.01% 2011
2015
Q2
$44.8M Buy
1,951,623
+61,414
+3% +$1.43M ﹤0.01% 2000
2015
Q1
$51M Buy
1,890,209
+93,564
+5% +$2.39M ﹤0.01% 1900
2014
Q4
$52M Buy
1,796,645
+11,064
+0.6% +$300K ﹤0.01% 1812
2014
Q3
$48M Buy
1,785,581
+14,471
+0.8% +$345K ﹤0.01% 1814
2014
Q2
$39.2M Sell
1,771,110
-19,949
-1% -$459K ﹤0.01% 1949
2014
Q1
$48.9M Buy
1,791,059
+80,683
+5% +$2.35M ﹤0.01% 1823
2013
Q4
$52.8M Buy
1,710,376
+45,620
+3% +$1.17M ﹤0.01% 1756
2013
Q3
$47.3M Buy
1,664,756
+52,133
+3% +$1.42M ﹤0.01% 1752
2013
Q2
$41.2M Buy
+1,612,623
New +$37.8M ﹤0.01% 1757

Other funds holding QDEL

Vanguard Group's QDEL Position: Q4 2025 in Review

Vanguard Group reduced its QuidelOrtho (QDEL) stake by 0.84% in Q4 2025, selling an estimated $1.74M and leaving 7,572,075 shares worth $216M. The position accounts for ﹤0.01% of the portfolio, ranked #1511.

Vanguard Group first reported a position in QDEL in Q2 2013 and has held it in 51 quarters since. The position peaked at $801M in Q2 2020. 243 funds tracked by Wall St. Rank hold QDEL as of Q4 2025.

  • Vanguard Group held 7,572,075 shares of QuidelOrtho worth $216M as of Q4 2025.
  • Vanguard Group sold 64,118 QuidelOrtho shares in Q4 2025, an estimated $1.74M.
  • QuidelOrtho made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #1511 holding.
  • Vanguard Group first reported a position in QuidelOrtho in Q2 2013 and has held it in 51 quarters since.
  • Vanguard Group's QuidelOrtho position peaked at $801M in Q2 2020.
  • 243 funds tracked by Wall St. Rank held QuidelOrtho as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.